Amyloid-β42Biomarker2 papersHumans1LatestNov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 2Oct 2026: 03Frontiers in NeurologyReview·YesterdayAssociations between obstructive sleep apnea and Alzheimer's disease-related biomarkers (amyloid-β and tau) in blood and cerebrospinal fluid: a systematic review and meta-analysisObstructive sleep apneaJournal of Alzheimer's DiseaseHumans·1 OctExploring the interplay between frailty, Alzheimer's disease biomarkers, and cognitive functioning in patients with mild cognitive impairment: A cross-sectional studyMild cognitive impairmentDiagnosticsHumans·15 SepPlasma Glial Fibrillary Acidic Protein and Neurofilament Light Chain Concentrations Are Inversely Associated with Retinal Microvascular Perfusion and Vessel Density in Cognitively Normal Individuals with Familial or Genetic Risk Factors for Alzheimer's DiseaseNfLGSA 2024 AbstractHumans·1 JanASSOCIATION BETWEEN SERUM BIOMARKERS OF ALZHEIMER’S DISEASE AND “DUAL DECLINE” IN COGNITIVE AND MOTOR FUNCTIONSBiomarkers
Frontiers in NeurologyReview·YesterdayAssociations between obstructive sleep apnea and Alzheimer's disease-related biomarkers (amyloid-β and tau) in blood and cerebrospinal fluid: a systematic review and meta-analysisObstructive sleep apnea
Journal of Alzheimer's DiseaseHumans·1 OctExploring the interplay between frailty, Alzheimer's disease biomarkers, and cognitive functioning in patients with mild cognitive impairment: A cross-sectional studyMild cognitive impairment
DiagnosticsHumans·15 SepPlasma Glial Fibrillary Acidic Protein and Neurofilament Light Chain Concentrations Are Inversely Associated with Retinal Microvascular Perfusion and Vessel Density in Cognitively Normal Individuals with Familial or Genetic Risk Factors for Alzheimer's DiseaseNfL
GSA 2024 AbstractHumans·1 JanASSOCIATION BETWEEN SERUM BIOMARKERS OF ALZHEIMER’S DISEASE AND “DUAL DECLINE” IN COGNITIVE AND MOTOR FUNCTIONSBiomarkers